参考文献:

[ 1 ] 　Fan JG, Saibara T, Chitturi S, et al. What are the risk factors andsettings for non2alcoholic fatty liver disease in Asia2Pacific? [ J ]. JGastroenterol Hetatol, 2007, 22 (6) : 7942800.

[ 2 ] 　Chen CH, HuangMH, Yang JC, et al. Prevalence and risk factors ofnonalcoholic fatty liver disease in an adult population of taiwan:metabolic significance of nonalcoholic fatty liver disease in nono2bese adults[ J ]. J Clin Gastroenterol, 2006, 40 (8) : 7452752.

[ 3 ] 　Gambarin2GelwanM, Kinkhabwala SV, Schiano TD, et al. Prevalenceof nonalcoholic fatty liver disease in women with polycystic ovary syn2drome[ J ]. Clin Gastroenterol Hepatol, 2007, 5 (4) : 4962501.

[ 4 ] 　Falck2Ytter Y, Younossi ZM,Marehesini G, et al. Clinical featuresand natural history of non2alcoholic steatosis syndromes[ J ]. SeminLiverDis, 2001, 21 (1) : 17226.

[ 5 ] 　Sung KC, RyanMC, Kim BS, et al. Relationship s between estimatesof adiposity, insulin resistance and nonalcoholic fatty liver diseasein a large group of nondiabetic Korean adults[ J ]. Diatebes Care,2007, 30 (8) : 211322118.

[ 6 ] 　Sartorio A, Del Col A, Agosti F, et al. Predictors of nonalcoholicfatty liver disease in obese children[ J ]. Eur J Clin Nutr, 2007, 61(7) : 8772883.

[ 7 ] 　Targher G,Bertolini L, Rodella S, et al. Associations between p las2ma adiponectin concentrations and liver histology in patients withnonalcoholic fatty liver disease[ J ]. Clin Endocrinol (Oxf) , 2006,64 (6) : 6792683.

[ 8 ] 　Kaser S,Moschen A, Cayon A, et al. Adiponectin and its recep torsin nonalcoholic steatohepatitis[ J ]. Gut, 2005, 54 (1) : 1172121.

[ 9 ] 　Wong VW, HuiAY, Tsang SW, et al. Metabolic and adipokine p ro2file of Chinese patients with nonalcoholic fatty liver disease [ J ].Clin Gastroenterol Hepatol, 2006, 4 (9) : 115421161.

[ 10 ] 　Haukeland JW, Dam?s JK, Konop ski Z, et al. Systemic inflamma2tion in nonalcoholic fatty liver disease is characterized by elevatedlevels of CCL2 [ J ]. J Hepatol, 2006, 44 (6) : 116721174.

[ 11 ] 　Crespo J, Cayon A, Fernandez2Gil P, et al. Gene exp ression oftumor necroxis factor alpha and TNF2recep tors, p55 and p75, innonalcoholic steatohepatitis patients [ J ]. Hepatology, 2001, 34(6) : 115821163.

[ 12 ] 　Tokushige K, Takakura M, Tsuchiya2Matsushita N, et al. Influenceof TNF gene polymorphisms in Japanese patients with NASH andsimp le steatosis[ J ]. J Hepatol, 2007, 46 (6) : 110421110.

[ 13 ] 　BajajM, Suraamornkul S, HardiesLJ, et al. Plasma resistin concen2tration, hepatic fat content, and hepatic and peripheral insulin re2sistance in p ioglitazone2treated type Ⅱdiabetic patients [ J ]. Int JObes RelatMetab Disord, 2004, 28 (6) : 7832789.

[ 14 ] 　Pagano C, Soardo G, Pilon C, et al. Increased serum resistin in non2alcoholic fatty liver disease is related to liver disease severity andnot to insulin resistance [ J ]. J Clin Endocrinol Metab, 2006, 91(3) : 108121086.

[ 15 ] 　Lizardi2Cervera J, Chavez2Tap ia NC, Pérez2Bautista O, et al. Asso2ciation among C2reactive p rotein, fatty liver disease, and cardiovas2cular risk[ J ]. Dig Dis Sci, 2007, 52 (9) : 237522379.

[ 16 ] 　YonedaM,Mawatari H, Fujita K, et al. High2sensitivity C2reactivep rotein is an independent clinical feature of nonalcoholic steatohep2atitis(NASH) and also of the severity of fibrosis in NASH [ J ]. JGastroenterol, 2007, 42 (7) : 5732582.

[ 17 ] 　Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduceER stress and restore glucose homeostasis in amouse model of type2 diabetes[ J ]. Science, 2006, 313 (5790) : 113721140.

[ 18 ] 　Imai Y,Varela GM, JacksonMB, et al. Reduction of hepatosteatosisand lip id levels by an adipose differentiation2related p rotein anti2sense oligonucleotide [ J ]. Gastroenterology, 2007, 132 ( 5 ) : 194721954.

[ 19 ] 　Macdonald J, Srinivasan M,More R. Percutaneous coronary inter2vention in a patient with vonWillebrand′s disease p resenting withan acute coronary syndrome[ J ]. J Invasive Cardiol, 2006, 18 ( 4) :1742177.

[ 20 ] 　HamaguchiM, Kojima T, Takeda N, et al. Nonalcoholic fatty liverdisease is a novel p redictor of cardiovascular disease [ J ]. World JGastroenterol, 2007, 13 (10) : 157921584.

[ 21 ] 　ShimadaM, Kawahara H,Ozaki K, et al. Usefulness of a combinedevaluation of the serum adiponectin level, hOMA2IR, and serumtype IV collagen 7S level to p redict the early stage of nonalcoholicsteatohepatitis[ J ]. Am J Gastroenterol, 2007, 102 (9) : 193121938.

[ 22 ] 　MancoM, Marcellini M, Giannone G, et al. Correlation of serumTNF2alpha levels and histologic liver injury scores in pediatric non2alcoholic fatty liver disease[ J ]. Am J Clin Pathol, 2007, 127 ( 6) :9542960.